Pharmaceuticals
Allergen deal to help Pfizer save $35 bn in annual taxes: report
26 Feb 2016
The Pfizer-Allergen deal is the largest inversion ever, which would potentially lower the merged entity's annual tax bill by $35 billion in the United States